文献速递生殖医学

阶梯式与传统克罗米芬方案在多囊卵巢综合征中的系统评价与荟萃分析

Stair-step versus traditional clomiphene citrate protocols in polycystic ovary syndrome: a systematic review and meta-analysis.
PubMed 文献 · Reprod Biomed Online · 2026-06-17

该系统评价与荟萃分析纳入5项随机对照试验(n=520),比较阶梯式克罗米芬方案(SSP)与传统方案在多囊卵巢综合征患者中的促排卵效果。结果显示SSP提高排卵率(RR 1.28,95%CI 1.10–1.49)和临床妊娠率(RR 1.46,95%CI 1.04–2.05),缩短治疗时间(平均差-32.59天),子宫内膜厚度无显著差异。

要点

  • 阶梯式克罗米芬方案可提高PCOS患者排卵率(RR 1.28)。
  • 阶梯式方案可能提高临床妊娠率,但结果主要由一项研究驱动。
  • 阶梯式方案缩短治疗时间约32.59天,子宫内膜厚度无差异。

核心结论

  • 阶梯式克罗米芬方案提高排卵率并缩短治疗时间,且不影响子宫内膜厚度,可能提高临床妊娠率。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、Cochrane Library、ClinicalTrials.gov、EMBASE和Google Scholar从建库至2025年6月15日。
  • 纳入5项随机对照试验,共520例患者(SSP组255例,传统方案组265例),使用Review Manager 5.4进行随机效应模型分析。

主要发现

  • 排卵率:SSP组优于传统方案(RR 1.28,95%CI 1.10–1.49;5项RCT,n=520,I²=0%)。
  • 临床妊娠率:SSP组优于传统方案(RR 1.46,95%CI 1.04–2.05;4项RCT,n=460,I²=0%),但结果主要由一项研究驱动。
  • 治疗时间:SSP组缩短(平均差-32.59天,95%CI -38.66至-26.52天;3项RCT,n=320,I²=83%)。
  • 子宫内膜厚度:两组相似(平均差0.32 mm,95%CI -0.95至1.59 mm;4项RCT,n=460,I²=91%)。

临床怎么用

  • 对于PCOS患者促排卵,可考虑采用阶梯式克罗米芬方案以更快达到排卵并提高排卵率。
  • 临床妊娠率获益需谨慎解读,因结果主要由单项研究驱动。

局限性

  • 临床妊娠率结果主要由一项研究驱动。
  • 治疗时间和子宫内膜厚度的分析存在显著异质性(I²分别为83%和91%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This review explores whether the clomiphene citrate stair-step protocol (SSP) for ovulation induction in patients with polycystic ovary syndrome (PCOS) outperforms the traditional protocol. The following databases were searched: PubMed, Cochrane Library, ClinicalTrials.gov, EMBASE and Google Scholar from inception to 15 June 2025, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and with PROSPERO registration (CRD420251050294). Of 847 screened records, five randomized controlled trials were included (n = 520: SSP: n = 255; traditional protocol: n = 265). Analyses were conducted in Review Manager 5.4 using random-effects models. Risk ratios, mean differences and 95% confidence intervals were calculated. Heterogeneity was assessed with I², risk of bias with RoB2, certainty with GRADE and robustness with leave-one-out sensitivity analysis. The SSP increased ovulation rates compared with the traditional protocol (RR 1.28, 95% CI 1.10 to 1.49; five randomized controlled trials [RCTs], n = 520, I² = 0%). Clinical pregnancy also favoured SSP (RR 1.46, 95% CI 1.04 to 2.05; four RCTs, n = 460; I² = 0%), although this result was largely driven by one study. The SSP shortened treatment duration (mean difference -32.59 days, 95% CI -38.66 to -26.52 days; three RCTs, n = 320, I² = 83%). Endometrial thickness was similar (mean difference 0.32 mm, 95% CI -0.95 to 1.59 mm; four RCTs, n = 460, I² = 91%). SSP improves ovulation rate and shortens treatment without affecting endometrial thickness and may increase clinical pregnancy rates.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Reimão Miller KA, Dos Santos PL, Fernandes Oliveira Amador W, et al. Stair-step versus traditional clomiphene citrate protocols in polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biomed Online. 2026. PMID: 42508166. doi:10.1016/j.rbmo.2026.105826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。